Table 3 The results of the budget impact analysis

Iran population

87,406,253

88,455,128

89,516,589

90,590,788

91,677,878

men population

43,703,126

44,227,564

44,758,295

45,295,394

45,838,939

mCRPC patients

3,846

3,892

3,939

3,986

4,034

enzalutamide market share

0.05

0.1

0.15

0.2

0.25

Scenario 1(without Enzalutamide)

39,055,041

39,523,702

39,997,986

40,477,962

40,963,697

Scenario 2(with Enzalutamide)

39,465,858

40,355,195

41,260,194

42,181,101

43,118,168

Financial impact

410,817

831,493

1,262,208

1,703,139

2,154,470